How Sanofi's setback could lead to better dengue vaccines

CHICAGO (Reuters) - New dengue vaccines being developed by Takeda Pharmaceuticals Co Ltd and U.S. government scientists are poised to provide a safer alternative to Sanofi's Dengvaxia, according to vaccine experts, because they already take into account some of the issues that sidelined the product last year.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news